Pernazine

Pernazine

perphenazine

Manufacturer:

Atlantic Lab

Distributor:

Atlantic Pharma
Concise Prescribing Info
Contents
Perphenazine
Indications/Uses
Antipsychotic in schizophrenia, antiemetic.
Dosage/Direction for Use
Adult 16-64 mg daily, in 2-4 divided doses. Childn >12 yr 6-12 mg, 6-12 yr 6 mg, 1-6 yr 4 mg. To be taken in 3 divided doses.
Administration
Should be taken with food.
Contraindications
Bone marrow depression, comatose states.
Special Precautions
Pregnancy, lactation, elderly, debilitated childn. Impaired liver or kidney function, CV or resp disorders, parkinsonism, diabetes, pheochromocytoma, epilepsy, glaucoma. May impair temp regulatory mechanism.
Adverse Reactions
Drowsiness, dependence, antimuscarinic effects, insomnia, depression, convulsions, agitation, tachycardia, postural hypotension, allergic reactions, agranulocytosis, tardive dyskinesia, impaired glucose tolerance.
Drug Interactions
Alcohol, CNS depressants, guanethidine, anticholinergics.
ATC Classification
N05AB03 - perphenazine ; Belongs to the class of phenothiazine antipsychotics with piperazine structure. Used in the management of psychosis.
Presentation/Packing
Form
Pernazine tab 2 mg
Packing/Price
1000's
Form
Pernazine tab 4 mg
Packing/Price
1000's
Form
Pernazine tab 8 mg
Packing/Price
1000's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in